Pharmafile Logo

Vaccine hesitancy eBook

June 7, 2021 | #COVID19, coronavirus, vaccines 

In this e-book, we answer the difficult questions around vaccine hesitancy. Our consultants and commercial experts explore the behavioural science and reveal strategies for improving uptake.

- PMLiVEToday, all eyes are on vaccines. At its high, the US administered 3.4 million doses of the COVID-19 vaccines per day, but in April, this number dwindled to 2.2 million per day. The vulnerable and those who passionately support the vaccines had queued up to become the first to be immunized, sometimes driving hours to get their shot.

However, now that the most enthusiastic populations have been vaccinated, life science companies, healthcare professionals, and the government are up against the challenging task of coaxing the 31% of Americans who are vaccine-hesitant into signing up for the vaccine.

States, corporations, and vaccination centers are even offering incentives from doughnuts and free beer, to savings bonds and marijuana to stimulate demand for vaccines.

In this downloadable pack, we interview industry-leading stakeholders and provide expert analysis from our consultants and commercial experts. Download the PDF to explore:

  • Original research findings on the deeper drivers behind vaccine hesitancy and the benefits of taking a human-centred approach for increasing vaccine uptake
  • The current landscape, expert analysis, and advice for improving vaccine uptake
  • The motivations behind the Arm in Arm campaign, a global campaign designed to encourage donations to ensure everyone across the globe has access to a lifesaving COVID-19 vaccine
  • The social and political drivers fuelling the anti-vax movement
  • The differences between the US and UK immunization programs
  • Why our consultants are volunteering to be part of the UK immunization program

DOWNLOAD THE EBOOK HERE

This content was provided by Avalere Health

Company Details

 Latest Content from  Avalere Health 

What does the future hold for Medical Affairs?

Lori Lush, Head of Fishawack Medical, reveals why she’s driven to tell impactful scientific stories, the benefits of cross-functional collaboration, and the trends she predicts for the next five years.

Unpacking rare diseases in the first edition of Delta magazine

Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization.

Fishawack Health unveils an unrivaled global market access and HEOR offering with the acquisition of PRMA Consulting

Fishawack Health bolsters its strong strategic offering by acquiring PRMA Consulting – a global market access and HEOR consulting leader with significant expertise in US, EU, and Asia-Pacific markets

Fishawack acquires creative consultancy Blue Latitude Health

The Fishawack Group has acquired Blue Latitude Health, based in London, UK, and New York, USA. Blue Latitude Health is a creative consultancy combining the commercial focus of a consultancy...

Fishawack launches new website and introduces new structure for growth

The Fishawack Group has launched their new website, introducing the company’s new two-division structure, Fishawack Medical Communications and Fishawack Creative. The new site showcases the Group's capabilities as well as...